Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Preformulation is the stage of development during which the physicochemical properties of the drug substance are characterised and established. Knowledge of the relevant physiochemical and biopharmaceutical properties determines the appropriate formulation and delivery method for Pre-Clinical and Phase 1 studies.
Through the creation of synergy between solid state chemistry and formulation development, our experienced scientists have the ability to add great value to your pre-clinical project, while decreasing timelines.
We have continued to strengthen our crystallisation development capabilities by the acquisition of BlazeMetrics process analytical technology, which provides real time In-Process high resolution microscopy, analytics, and spectroscopy in a single probe, thus enabling us to better understand the critical parameters that affect crystallisation and to develop robust, scalable crystallisation processes.